Quality Measures for Mild Cognitive Impairment

How can we provide the best care for those with mild cognitive impairment?

Sponsoring Organization: American Academy of Neurology Quality and Safety Subcommittee

Background and Objective

Mild cognitive impairment (MCI) is associated with objective cognitive impairment and minimal changes in functional ability. Etiologies include both neurodegenerative and non-neurodegenerative causes. The worldwide prevalence of MCI, estimated at 7% for those aged 60 to 64, increases to about 38% in those aged ≥85. The American Academy of Neurology Quality and Safety Subcommittee has now developed six quality measurements for MCI, to accompany guidelines published in 2018 (NEJM JW Neurol Mar 2018 and Neurology 2018; 90:126).

Key Points

Annual cognitive health assessment for patients aged 65 and older

Age is a risk factor for MCI, and p…

Reviewing Author

Jennifer Rose V. Molano, MD

Disclosures

Grant/Research SupportNational Center for Advancing Translational Science – Cincinnati Center for Clinical and Translational Science and Training

Editorial BoardsBrain & Life